{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:08:54Z","timestamp":1792843734425,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Health Technology R&D Project","award":["HI14C1277"],"award-info":[{"award-number":["HI14C1277"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1835-9","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T08:03:04Z","timestamp":1550131384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":173,"title":["Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Jeong Seok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-3437","authenticated-orcid":false,"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"9842","key":"1835_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","volume":"380","author":"A Fischer","year":"2012","unstructured":"Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380(9842):689\u201398.","journal-title":"Lancet"},{"issue":"7","key":"1835_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","volume":"175","author":"JH Park","year":"2007","unstructured":"Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175(7):705\u201311.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1835_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1378\/chest.08-0053","volume":"134","author":"A Fischer","year":"2008","unstructured":"Fischer A, Swigris JJ, Groshong SD, Cool CD, Sahin H, Lynch DA, et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest. 2008;134(3):601\u20135.","journal-title":"Chest"},{"issue":"6","key":"1835_CR4","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","volume":"127","author":"HK Lee","year":"2005","unstructured":"Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127(6):2019\u201327.","journal-title":"Chest"},{"key":"1835_CR5","doi-asserted-by":"publisher","first-page":"h6819","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.","journal-title":"BMJ"},{"issue":"25","key":"1835_CR6","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006;354(25):2655\u201366.","journal-title":"N Engl J Med"},{"issue":"10","key":"1835_CR7","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/rheumatology\/kev121","volume":"54","author":"HM Kwon","year":"2015","unstructured":"Kwon HM, Kang EH, Park JK, Go DJ, Lee EY, Song YW, et al. A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2015;54(10):1792\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1835_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1513\/pats.200703-045MS","volume":"4","author":"KK Brown","year":"2007","unstructured":"Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc. 2007;4(5):443\u20138.","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"1835_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"135","key":"1835_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","volume":"24","author":"M Shaw","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015;24(135):1\u201316.","journal-title":"Eur Respir Rev"},{"key":"1835_CR11","doi-asserted-by":"publisher","unstructured":"Yang JA, Lee JS, Park JK, Lee EB, Song YW, Lee EY. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis. Korean J Intern Med. 2017. \n                    https:\/\/doi.org\/10.3904\/kjim.2016.349\n                    \n                  .","DOI":"10.3904\/kjim.2016.349"},{"issue":"3","key":"1835_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1378\/chest.12-0741","volume":"143","author":"R Vij","year":"2013","unstructured":"Vij R, Strek ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013;143(3):814\u201324.","journal-title":"Chest"},{"issue":"4","key":"1835_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-2007-985610","volume":"28","author":"AU Wells","year":"2007","unstructured":"Wells AU. Pulmonary function tests in connective tissue disease. Semin Respir Crit Care Med. 2007;28(4):379\u201388.","journal-title":"Semin Respir Crit Care Med"},{"key":"1835_CR14","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1148\/radiographics.22.suppl_1.g02oc04s151","volume":"22","author":"EA Kim","year":"2002","unstructured":"Kim EA, Lee KS, Johkoh T, Kim TS, Suh GY, Kwon OJ, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics. 2002;22:S151\u201365.","journal-title":"Radiographics"},{"issue":"4","key":"1835_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar3097","volume":"12","author":"FV Castelino","year":"2010","unstructured":"Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12(4):213.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"1835_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/01.rti.0000213572.16904.40","volume":"22","author":"RM Shah","year":"2007","unstructured":"Shah RM, Jimenez S, Wechsler R. Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis. J Thorac Imaging. 2007;22(2):120\u20134.","journal-title":"J Thorac Imaging"},{"issue":"Suppl 5","key":"1835_CR17","doi-asserted-by":"publisher","first-page":"v59","DOI":"10.1093\/rheumatology\/ken271","volume":"47","author":"AU Wells","year":"2008","unstructured":"Wells AU. High-resolution computed tomography and scleroderma lung disease. Rheumatology (Oxford). 2008;47(Suppl 5):v59\u201361.","journal-title":"Rheumatology (Oxford)"},{"key":"1835_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1465-9921-6-78","volume":"6","author":"A Tzouvelekis","year":"2005","unstructured":"Tzouvelekis A, Kouliatsis G, Anevlavis S, Bouros D. Serum biomarkers in interstitial lung diseases. Respir Res. 2005;6:78.","journal-title":"Respir Res"},{"issue":"1","key":"1835_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012;50(1):3\u201313.","journal-title":"Respir Investig"},{"issue":"10","key":"1835_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3899\/jrheum.160339","volume":"43","author":"M Kuwana","year":"2016","unstructured":"Kuwana M, Shirai Y, Takeuchi T. Elevated serum Krebs von den Lungen-6 in early disease predicts subsequent deterioration of pulmonary function in patients with systemic sclerosis and interstitial lung disease. J Rheumatol. 2016;43(10):1825\u201331.","journal-title":"J Rheumatol"},{"key":"1835_CR21","doi-asserted-by":"crossref","unstructured":"Salazar GA, Kuwana M, Wu M, Estrada YMRM, Ying J, Charles J, et al. KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease. J Rheumatol. 2018;45(8):1153\u20138.","DOI":"10.3899\/jrheum.170518"},{"issue":"5","key":"1835_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00296-018-3987-3","volume":"38","author":"A Benyamine","year":"2018","unstructured":"Benyamine A, Heim X, Resseguier N, Bertin D, Gomez C, Ebbo M, et al. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Rheumatol Int. 2018;38(5):813\u20139.","journal-title":"Rheumatol Int"},{"issue":"6","key":"1835_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2796.2011.02459.x","volume":"271","author":"M Fathi","year":"2012","unstructured":"Fathi M, Barbasso Helmers S, Lundberg IE. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. J Intern Med. 2012;271(6):589\u201397.","journal-title":"J Intern Med"},{"issue":"1","key":"1835_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-017-1506-7","volume":"20","author":"Y Sugiyama","year":"2018","unstructured":"Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, et al. The predictive prognostic factors for polymyositis\/dermatomyositis-associated interstitial lung disease. Arthritis Res Ther. 2018;20(1):7.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1835_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/jcla.20404","volume":"24","author":"K Miyazaki","year":"2010","unstructured":"Miyazaki K, Kurishima K, Kagohashi K, Kawaguchi M, Ishikawa H, Satoh H, et al. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease. J Clin Lab Anal. 2010;24(5):295\u20139.","journal-title":"J Clin Lab Anal"},{"issue":"10","key":"1835_CR26","first-page":"4069","volume":"6","author":"Y Ogawa","year":"2000","unstructured":"Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, et al. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res. 2000;6(10):4069\u201372.","journal-title":"Clin Cancer Res"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1835-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T19:20:36Z","timestamp":1581621636000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1835-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1835-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"10 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in compliance with the Declaration of Helsinki and was approved by the Institutional Review Board of Seoul National University Hospital (IRB#:0408-131-010). All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"58"}}